Spots Global Cancer Trial Database for clolar
Every month we try and update this database with for clolar cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) | NCT01444742 | Leukemia Myeloproliferat... | Clofarabine Cytarabine | 18 Years - | M.D. Anderson Cancer Center | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors | NCT00125827 | Solid Tumors | clofarabine (or... | 18 Years - | Sanofi | |
| Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors | NCT00125827 | Solid Tumors | clofarabine (or... | 18 Years - | Sanofi | |
| A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) | NCT00317642 | Acute Myelogeno... | clofarabine (IV... placebo cytarabine | 55 Years - | Sanofi | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia | NCT00044889 | Acute Myelogeno... | clofarabine (IV... | 18 Years - | Sanofi | |
| Clofarabine in Adult Patients With Advanced Solid Tumors | NCT00125840 | Solid Tumors Leukemia, Lymph... Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Myelodysplastic... | clofarabine (IV... | 18 Years - | Sanofi | |
| Oral Clofarabine Study in Patients With Myelodysplastic Syndrome | NCT00299156 | Myelodysplastic... Chronic Myelomo... | Clofarabine | - | M.D. Anderson Cancer Center | |
| Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation | NCT00990249 | Leukemia Lymphoma Allogeneic Haem... Acute Lymphobla... | Busulfan Clofarabine Thymoglobulin Stem Cell Trans... | - 65 Years | M.D. Anderson Cancer Center | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Clofarabine in Adult Patients With Advanced Solid Tumors | NCT00125840 | Solid Tumors Leukemia, Lymph... Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Myelodysplastic... | clofarabine (IV... | 18 Years - | Sanofi | |
| A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable | NCT00924443 | Acute Myeloid L... | clofarabine | 65 Years - | Sanofi | |
| Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia | NCT00081887 | Chronic Lymphoc... Leukemia | Clofarabine | - | M.D. Anderson Cancer Center | |
| A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) | NCT00317642 | Acute Myelogeno... | clofarabine (IV... placebo cytarabine | 55 Years - | Sanofi | |
| Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction | NCT01025154 | Acute Myeloid L... | Clofarabine Idarubicin Cytarabine | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Clofarabine in Adult Patients With Advanced Solid Tumors | NCT00125840 | Solid Tumors Leukemia, Lymph... Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Myelodysplastic... | clofarabine (IV... | 18 Years - | Sanofi | |
| A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable | NCT00924443 | Acute Myeloid L... | clofarabine | 65 Years - | Sanofi | |
| Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma | NCT00644189 | Follicular Lymp... Marginal Zone L... Mantle Cell Lym... Small Lymphocyt... Lymphoplasmacyt... Low Grade B-cel... Diffuse Large B... Peripheral T-ce... Angioimmunoblas... Anaplastic Larg... | Clofarabine | 18 Years - | Massachusetts General Hospital | |
| Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia | NCT00081887 | Chronic Lymphoc... Leukemia | Clofarabine | - | M.D. Anderson Cancer Center | |
| Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome | NCT01289457 | Leukemia | Clofarabine Idarubicin Cytarabine Fludarabine | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation | NCT00990249 | Leukemia Lymphoma Allogeneic Haem... Acute Lymphobla... | Busulfan Clofarabine Thymoglobulin Stem Cell Trans... | - 65 Years | M.D. Anderson Cancer Center | |
| Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) | NCT00042341 | Leukemia, Lymph... | clofarabine (IV... | - 21 Years | Sanofi | |
| PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias | NCT01169012 | Myelodysplastic... Acute Myeloid L... Acute Lymphobla... Chronic Myelomo... | Clofarabine | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma | NCT00644189 | Follicular Lymp... Marginal Zone L... Mantle Cell Lym... Small Lymphocyt... Lymphoplasmacyt... Low Grade B-cel... Diffuse Large B... Peripheral T-ce... Angioimmunoblas... Anaplastic Larg... | Clofarabine | 18 Years - | Massachusetts General Hospital | |
| Oral Clofarabine for Acute Myeloid Leukemia | NCT00727766 | Leukemia, Myelo... | Clofarabine | 60 Years - | Washington University School of Medicine | |
| Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients | NCT00042354 | Leukemia, Myelo... | clofarabine (IV... | - 21 Years | Sanofi | |
| A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. | NCT00315705 | Acute Lymphobla... Acute Myelogeno... Relapsed Leukem... | clofarabine Etoposide Cyclophosphamid... | 1 Year - 21 Years | Sanofi | |
| Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome | NCT01289457 | Leukemia | Clofarabine Idarubicin Cytarabine Fludarabine | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Oral Clofarabine for Acute Myeloid Leukemia | NCT00727766 | Leukemia, Myelo... | Clofarabine | 60 Years - | Washington University School of Medicine | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
